China Pharma Inc.

AI Score

0

Unlock

0.21
0.01 (4.90%)
At close: Jan 15, 2025, 12:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Net Income -3.08M -3.97M -3.40M -2.87M -20.70M -10.75M -19.28M -9.18M -15.41M -26.05M -20.01M 4.62M 19.27M 23.41M 20.23M 17.83M 12.82M 8.59M 3.80M -504.29K -226.37K -1.10M
Depreciation & Amortization 2.75M 2.70M 3.09M 2.68M 2.93M 3.26M 3.29M 3.08M 3.60M 1.79M 1.61M 1.46M 1.17M 1.51M 1.37M 719.48K 422.44K 397.00K 250.18K 504.19K 67.27K 83.31K
Stock-Based Compensation n/a 78.27K 15.24K n/a n/a n/a n/a n/a n/a n/a n/a 141.72K 196.18K 345.42K 41.80K 123.79M n/a n/a n/a n/a n/a n/a
Other Working Capital 246.86K 547.17K -520.41K 169.74K -12.88K -99.40K -51.02K 265.93K -1.43M -139.07K 218.66K 724.16K 1.63M -2.41M 1.88M 15.20K -6.37M -6.59M -3.67M n/a n/a n/a
Other Non-Cash Items 29.63K -93.85K 250.00K 115.19K 17.27M 8.04M 15.70M 3.96M -1.74M -1.06M 6.12M 3.23M -826.17K -1.08M -144.66M -123.67M -580.92K 87.61K 86.06K -106.22K 26.69K 693.59K
Deferred Income Tax n/a n/a -255.22K n/a n/a 68.42K 122.63K 308.18K 60.44K 77.04K 1.06M -430.25K 37.28K -123.18K 142.85M -257.45K -162.87K n/a n/a n/a n/a n/a
Change in Working Capital -404.15K 878.34K 51.79K 29.86K 1.11M 642.25K 1.01M 3.64M 4.65M 9.17M 9.05M -5.38M -14.61M -16.27M -9.16M -11.88M -9.70M -10.81M -4.58M 70.51K 39.28K 28.04K
Operating Cash Flow -699.69K -409.55K -249.84K -42.26K 608.31K 1.26M 841.22K 2.90M 3.35M 4.57M 8.60M 3.64M 5.24M 7.79M 10.67M 6.54M 2.80M -1.74M -449.10K -35.81K -93.13K -299.20K
Capital Expenditures -11.52K -401.96K -438.06K -867.31K -136.00K -51.15K -136.48K -193.40K -2.32M -5.84M -19.09M -4.99M -5.54M -10.52M -15.36M -8.49M -2.99M -192.00K -484.13K n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -82.15K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a 423.69K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a n/a 423.69K -714.70K -298.63K -4.83M -5,273.50B -10,454.50B -15.22B -1.95M 1.51M n/a 142.61K 2.50K 32.58K -250.00K
Investing Cash Flow -11.52K -401.96K -438.06K -867.31K -136.00K -51.15K -136.48K -193.40K -1.90M -5.84M -19.09M -4.99M -5.63M -10.52M -15.36M -10.44M -1.48M -192.00K -341.52K 2.50K 32.58K -250.00K
Debt Repayment 73.14K -1.55M 4.60M 624.18K -1.73M -1.98M -1.48M -6.02M n/a 605.00K 12.32M 1.29M n/a 80.38K 1.32M -387.81K -4.12M 2.16M -6.32M n/a 31.61K 22.34K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -237.60K n/a n/a n/a
Other Financial Acitivies n/a -223.01K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 595.67K 2.58M 70.00K n/a n/a n/a n/a n/a n/a 476.70K
Financial Cash Flow 73.14K -1.77M 4.60M 624.18K -1.73M -1.98M -1.48M -6.02M n/a 605.00K 12.32M 1.29M 595.67K 2.66M 1.39M 8.88M -203.02K 2.11M 1.25M 31.61K 61.09K 537.78K
Net Cash Flow -606.13K -2.83M 3.90M -227.23K -1.28M -843.63K -635.59K -3.58M 952.97K -697.35K 1.96M -21.15K 358.77K 57.33K -3.29M 5.10M 1.17M 195.22K 461.22K -1.71K 536.00 -11.42K
Free Cash Flow -711.20K -811.51K -687.89K -909.57K 472.31K 1.21M 704.74K 2.70M 1.03M -1.27M -10.50M -1.34M -306.42K -2.73M -4.69M -1.95M -187.37K -1.93M -933.23K -35.81K -93.13K -299.20K